TELA Bio, Inc. Sustainability Profile
TELA Bio, Inc., a pioneering medical technology company headquartered in the United States, specialises in the development of innovative surgical solutions. Founded in 2012, TELA Bio has made significant strides in the field of regenerative medicine, focusing on advanced biomaterials for soft tissue reconstruction. The company’s flagship products, including the OviTex® line of biologic mesh, are designed to enhance healing and reduce complications in surgical procedures. TELA Bio's unique approach combines the benefits of biologic and synthetic materials, setting it apart in a competitive market. With a strong presence across major operational regions in the US, TELA Bio has established itself as a leader in the surgical implant industry, recognised for its commitment to improving patient outcomes and advancing surgical techniques.
DitchCarbon Score
How does TELA Bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TELA Bio, Inc.'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TELA Bio, Inc.'s reported carbon emissions
In 2023, TELA Bio, Inc., headquartered in the US, reported total carbon emissions of approximately 151,000 kg CO2e, all of which fall under Scope 3 emissions. Notably, the company has no reported Scope 1 or Scope 2 emissions, indicating that their direct operational activities and energy consumption do not contribute to their carbon footprint. Currently, TELA Bio has not established any specific reduction targets or initiatives, nor do they participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). This lack of formal commitments suggests that while the company is aware of its emissions profile, it has yet to implement a structured approach to carbon reduction. As TELA Bio continues to navigate its environmental responsibilities, the focus on Scope 3 emissions highlights the importance of addressing indirect emissions throughout its value chain. The absence of reduction targets may present an opportunity for the company to enhance its sustainability strategy in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | - |
| Scope 2 | - |
| Scope 3 | 151,000 |
How Carbon Intensive is TELA Bio, Inc.'s Industry?
How Carbon Intensive is TELA Bio, Inc.'s Location?
TELA Bio, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
TELA Bio, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
